Aurobindo Pharma subsidiary receives USFDA’s Institution Inspection Report; inventory rises over 4%
Aurobindo Pharma Ltd has knowledgeable the inventory exchanges that the corporate’s wholly-owned subsidiary APL Healthcare Ltd. has obtained institution inspection report (EIR) from the USFDA, classifying its manufacturing facility at Tirupati, Andhra Pradesh, as ‘voluntary motion indicated’ (VAI). The US FDA carried out an inspection on the firm’s unit located at Menakuru Village, Naidupeta Mandal, … Read more